ST. PAUL, Minn.--(BUSINESS WIRE)--Dec. 1, 2005--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval and market release of the IBI-1500T6 Cardiac Ablation Generator and Therapy(TM) electrophysiology (EP) catheters, expanding the Company's therapeutic EP portfolio with a new high-power, state-of-the-art ablation system.
